Novo makes unsolicited bid for Ablynx

Novo Nordisk A/S disclosed on 8 January that it has made a second unsolicited bid for Ablynx NV – this time for €2.6 billion.The Ablynx board has responded saying that the proposal "fundamentally undervalues the company and its future."

Full text available to subscribers only. Click here for information on subscribing to MedNous.